…
CareSpan Health, Inc., together with its subsidiaries, operates as a healthcare technology and services company in the United States. The company offers CareSpan Clinic, a clinic-in-the-cloud workflow-driven platform that integrates remote patient monitoring, diagnostic tools, patient electronic health records, care collaboration capabilities, patient engagement, e-prescribing, and lab ordering, as well as deliver primary and urgent care, and behavioral health care. It also engages in technology development and licensing activities; and provides management services. The company is headquartered in New York, New York.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Carespan Health Inc (CSPN.V) is listed on the TSX Venture Exchange, but public disclosures provide limited detail on its operations or product offerings. It appears associated with the healthcare sector, yet specific long-term growth drivers and revenue sources are not clearly disclosed. Investors may be interested in healthcare exposure but should consult company filings and announcements for substantiated information.
Key risks include thin trading and low liquidity, likely need for additional financing, and execution and regulatory risks typical of small-cap healthcare issuers.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Income before tax | -0.44M | -2.03M | -3.14M | -6.86M | - |
| Minority interest | - | 0.00M | 0.25M | 0.33M | - |
| Net income | -0.44M | -2.03M | -2.89M | -6.53M | - |
| Selling general administrative | 0.97M | 1.78M | 3.47M | 9.48M | - |
| Gross profit | 0.08M | 0.15M | 0.18M | 0.56M | - |
| Reconciled depreciation | - | 0.00M | 0.01M | 0.00M | - |
| Ebit | - | - | -3.60M | -3.73M | -3.23M |
| Ebitda | - | - | -3.13M | -5.43M | - |
| Operating income | -1.14M | -1.91M | -3.30M | -3.73M | - |
| Interest expense | 0.15M | 0.14M | 0.00M | 1.43M | 0.00M |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M | - |
| Net interest income | -0.17M | -0.16M | -0.03M | -1.44M | - |
| Income tax expense | - | - | - | - | -0.04M |
| Total revenue | 0.60M | 2.53M | 4.54M | 5.76M | - |
| Total operating expenses | 1.75M | 4.44M | 7.84M | 9.49M | - |
| Cost of revenue | 0.53M | 2.38M | 4.36M | 5.19M | - |
| Total other income expense net | 0.88M | 0.04M | 0.19M | -1.69M | - |
| Net income from continuing ops | -0.44M | -2.03M | -3.14M | -6.86M | - |
| Net income applicable to common shares | - | - | -2.89M | -6.53M | -5.79M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Total assets | 0.13M | 0.23M | 1.38M | 2.70M | - |
| Total liab | 2.95M | 2.51M | 2.26M | 3.40M | - |
| Total stockholder equity | -2.82M | -2.29M | -0.89M | -0.37M | - |
| Other current liab | - | - | 0.23M | 0.56M | 2.85M |
| Common stock | - | - | 17.13M | 15.21M | 3.47M |
| Capital stock | 17.29M | 17.29M | 17.13M | 15.21M | - |
| Retained earnings | -21.81M | -21.37M | -19.34M | -16.45M | -11.72M |
| Cash | 0.00M | 0.03M | 0.39M | 0.95M | - |
| Total current liabilities | 2.95M | 2.51M | 2.26M | 3.40M | 8.39M |
| Net debt | 0.32M | 0.19M | - | - | - |
| Short long term debt | 0.32M | 0.22M | - | - | - |
| Other stockholder equity | - | - | 1.32M | 0.88M | 2.33M |
| Property plant equipment | - | - | - | 0.07M | 0.00M |
| Total current assets | 0.13M | 0.23M | 1.38M | 2.63M | 2.46M |
| Net tangible assets | - | - | -0.89M | -0.37M | -5.92M |
| Net receivables | 0.12M | 0.19M | 0.99M | 1.62M | 0.83M |
| Accounts payable | 1.11M | 0.93M | 2.03M | 2.66M | 1.46M |
| Non current assets total | 0.00M | 0.00M | 0.00M | 0.07M | - |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Investments | 0.79M | 0.00M | -0.06M | -0.04M | -0.02M |
| Change to liabilities | - | - | -0.32M | 1.18M | 1.39M |
| Total cashflows from investing activities | - | - | -0.06M | -0.04M | -0.02M |
| Net borrowings | - | - | - | 0.40M | 3.19M |
| Total cash from financing activities | 0.10M | 1.28M | 1.80M | 2.45M | 3.19M |
| Change to operating activities | - | - | - | -0.02M | -0.03M |
| Net income | -0.44M | -2.03M | -2.89M | -6.53M | -5.79M |
| Change in cash | -0.03M | -0.36M | -0.55M | -0.53M | 1.47M |
| Begin period cash flow | 0.03M | 0.39M | 0.95M | 1.47M | - |
| End period cash flow | 0.00M | 0.03M | 0.39M | 0.95M | 1.47M |
| Total cash from operating activities | -0.91M | -1.64M | -2.29M | -2.91M | -1.70M |
| Issuance of capital stock | - | 0.00M | 2.05M | 2.83M | - |
| Depreciation | - | 0.00M | 0.01M | 0.00M | 0.00M |
| Change to account receivables | 0.07M | 0.79M | 0.63M | -0.78M | -0.82M |
| Other cashflows from financing activities | - | - | -0.25M | -0.78M | 0.01M |
| Change to netincome | - | - | 0.27M | 3.24M | 3.53M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.07M | 0.00M |
| Change in working capital | 0.08M | 0.25M | 0.32M | 0.38M | - |
| Stock based compensation | 0.01M | 0.03M | 0.00M | 0.41M | - |
| Other non cash items | 0.15M | 0.11M | -1.02M | 2.86M | - |
| Free cash flow | -0.91M | -1.64M | -2.29M | -2.97M | - |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| NURS Hydreight Technologies Inc |
0.07 2.32% |
3.09 | 406.00 | 25.91 | 7.85 | 20.38 | 7.45 | 109.02 |
| ADK Diagnos Inc |
- -% |
0.35 | - | 10.00 | 411.24 | 18.74 | 389.06 | -6.16 |
| NXG NexgenRX Inc. |
- -% |
0.66 | 39.00 | 32.68 | 1.55 | 4.64 | 1.39 | 7.84 |
| PTEC Principal Technologies Inc |
- -% |
0.32 | - | - | 62.75 | 355.42 | 72.08 | -0.81 |
CareSpan Health, Inc., together with its subsidiaries, operates as a healthcare technology and services company in the United States. The company offers CareSpan Clinic, a clinic-in-the-cloud workflow-driven platform that integrates remote patient monitoring, diagnostic tools, patient electronic health records, care collaboration capabilities, patient engagement, e-prescribing, and lab ordering, as well as deliver primary and urgent care, and behavioral health care. It also engages in technology development and licensing activities; and provides management services. The company is headquartered in New York, New York.
105 East, 34th Street, New York, NY, United States, 10016
303 800 8296
| Name | Title | Year Born |
|---|---|---|
| Mr. Rembert de Villa | Vice Chairman, Pres & CEO | 1957 |
| Dr. Terry R. Knapp M.D. | Founder & Advisor | 1944 |
| Ms. Leslie N. Markow (Illinois), C.Dir, CA, CPA | Chief Financial Officer | 1960 |
| Mr. Darrell Messersmith CHIO, MSPT | Head of Technology & Operations | NA |
| Mr. Douglas Wolfgram | Chief Technology Officer | NA |
| Dr. JoEllen Koerner M.S.N., Ph.D., R.N. | Chief Nursing Officer | NA |
| Dr. Sam Toney M.D., M.S. | Acting Chief Medical Officer | NA |
| Raj Dewan | Sec. | NA |
| Mr. Darrell Messersmith CHIO, MSPT | CEO & Director | NA |
| Mr. Rembert de Villa | President & Director | 1957 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.